Present status and future perspective of peptide-based vaccine therapy for urological cancer
Author:
Affiliation:
1. Department of Urology; Iwate Medical University School of Medicine; Morioka Japan
2. Division of Genome Medicine; Institute for Genome Research; Tokushima University; Tokushima Japan
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13506/fullpdf
Reference65 articles.
1. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus prodigiosus);Coley;Proc R Soc Med,1910
2. Cancer immunotherapy: moving beyond current vaccines;Rosenberg;Nat Med,2004
3. Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives;Milani;Ann Oncol,2013
4. Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer;Obara;Cancer Sci,2017
5. Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy;Noguchi;Prostate,2012
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unlocking Immunity: Innovative prostate cancer vaccine strategies;International Immunopharmacology;2024-12
2. The Role and Development of Peptide Vaccines in Cervical Cancer Treatment;International Journal of Peptide Research and Therapeutics;2024-05-24
3. Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?;Endokrynologia Polska;2024-03-19
4. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02
5. A new antiviral hypothesis and radioactive iodine therapy to other cancers, such as breast cancer, lung cancer, and glioblastoma multiforme (GBM)?;Endokrynologia Polska;2023-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3